Novolog Mix 70/30 Injection, Suspension
Product Images NDC 0169-2201

Product Visual Gallery

This gallery contains 51 technical images submitted to the FDA as part of the official labeling for Novolog Mix 70/30 (NDC 0169-2201). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novo Nordisk Pharmaceutical Industries, Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Molecular Chain Of Insulin Aspart. (Image 01)

Chemical structure diagram showing the amino acid sequences of the A-chain and B-chain of insulin aspart, indicating disulfide bonds and the specific arrangement of amino acids in both chains.*

FDA Label Image

Graph Showing Glucose Infusion Rate For Novolog Mix 0/30 (Image 02)

A line graph depicting glucose infusion rate (mg/kg*min) over 24 hours for NovoLog Mix 70/30. The curve shows a rapid increase peaking around 2 hours, followed by a gradual decline over the remaining time period.*

FDA Label Image

Graph Showing Mean Serum Insulin For Novolog Mix 70/30 (Image 03)

A line graph showing mean serum insulin levels (mU/L) over 24 hours for NovoLog Mix 70/30. The x-axis represents time in hours, and the y-axis shows mean serum insulin concentration. The graph includes error bars representing the standard error of the mean (SEM).*

FDA Label Image

Vial (Image 29)

Illustration of a vial showing a tamper-resistant cap and a rubber stopper under the cap, likely representing packaging components for an injectable suspension such as insulin aspart injection.*

FDA Label Image

Hand & Vial Figure (Image 36)

An instructional illustration showing a hand holding a small vial, demonstrating how to grip the vial, likely for injection of NovoLog Mix 70/30 insulin aspart suspension.*

FDA Label Image

Figure A & Figure B (Image 37)

An instructional illustration showing two hand positions opening a vial cap labeled as Figure A and Figure B. The images demonstrate how to remove the cap from a vial, likely related to the preparation of an injectable medication such as NovoLog Mix 70/30 insulin aspart suspension.*

FDA Label Image

Figure C (Image 38)

An instructional illustration showing the proper technique for holding a hand, with an arrow indicating a side-to-side motion. This figure likely demonstrates part of a method related to injection or medication administration.*

FDA Label Image

Figure D (Image 39)

Instructional illustration labeled as Figure D showing a hand holding a syringe above a vial with an arrow pointing downward, demonstrating the step of inserting the syringe needle into the vial for drawing medication.*

FDA Label Image

Figure E (Image 40)

An instructional illustration labeled Figure E, showing two hands preparing a syringe by drawing liquid medication from a vial into the syringe piston, demonstrating part of the injection preparation process.*

FDA Label Image

Figure F (Image 41)

An instructional illustration labeled as Figure F showing a hand holding a syringe and a vial, demonstrating how to draw medication from the vial with a downward arrow indicating the syringe plunger being pulled back.*

FDA Label Image

Figure G (Image 42)

Illustration showing a hand holding a vial of medication above a syringe with an arrow indicating the movement of the vial downward into the syringe, demonstrating how to draw insulin aspart suspension for subcutaneous injection.*

FDA Label Image

Figure H (Image 43)

An instructional illustration showing a person preparing an injection by drawing liquid from a vial into a syringe. The figure is labeled as Figure H and depicts the proper technique for filling the syringe from a vial for subcutaneous injection.*

FDA Label Image

Figure I (Image 44)

Instructional illustration showing a hand drawing NovoLog Mix 70/30 injection suspension from a vial into a syringe. The image depicts the vial being held upside down and the syringe needle inserted into the vial to withdraw the medication.*

FDA Label Image

Figure J (Image 45)

An illustration showing a hand holding a vial and a syringe with an arrow indicating to draw liquid from the vial into the syringe, demonstrating part of the injection preparation process.*

FDA Label Image

Image Of Possible Injection Sites. (Image 09)

An illustration showing front and back views of a human torso highlighting common subcutaneous injection sites in the abdomen and upper buttocks. This figure likely relates to proper administration areas for subcutaneous injections.*

FDA Label Image

Figure L (Image 47)

An instructional illustration showing hands preparing a syringe for injection. One hand holds the syringe while the other hand places a cap or needle onto the syringe, indicated by a downward arrow. No text or branding visible.*

FDA Label Image

Figure M (Image 48)

An instructional illustration labeled as Figure M showing a person preparing to administer a subcutaneous injection using a syringe into the forearm. The image depicts the correct hand position and angle for injection.*

FDA Label Image

Important (Image 10)

FDA Label Image

Flexpen Components (Image 04)

An exploded diagram of the NovoLog Mix 70/30 FlexPen showing its components from left to right: pen cap, rubber stopper, 12 glass units, ball, cartridge, cartridge scale, pointer, dose selector, and push-button. The diagram illustrates the FlexPen's assembly and dosing features for insulin aspart injection suspension.*

FDA Label Image

Needle Components. (Image 05)

Illustration showing needle components for three types of insulin needles: NovoFine, NovoFine Plus, and NovoTwist. Each type is displayed with individual parts labeled as big outer needle cap, inner needle cap, needle, and protective tab, illustrating their assembly or separation.*

FDA Label Image

Pull Off The Pen Cap. (Image 50)

An instructional illustration demonstrating the method to prepare or use a syringe for injection, showing fingers holding the syringe and an arrow indicating the direction for attaching or adjusting the needle or cap.*

FDA Label Image

Roll The Pen Between Your Palms. (Image 51)

An instructional illustration showing a person's hand holding a syringe and rotating the insulin vial by rolling it gently between the palms, indicating mixing the insulin suspension before injection.*

FDA Label Image

Move The Pen Up And Down. (Image 52)

Illustration showing a two-step process to prepare an injectable suspension. Step 1 depicts holding a vial upright, and Step 2 shows inverting or turning the vial downward. The image likely demonstrates mixing the insulin suspension before injection.*

FDA Label Image

Important (Image 11)

FDA Label Image

Figure D: Screw Needle On. (Image 06)

Instructional illustration showing use steps for NovoFine and NovoFine Plus needles with NovoTwist. The left panel depicts attaching a needle to a pen by pushing the needle onto the pen. The right panel shows twisting the NovoTwist needle to secure it in place.*

FDA Label Image

Figure E: Pull Off Outer Needle Cap. (Image 25)

An instructional illustration showing the connection of syringe components labeled 'NovoFine' or 'NovoFine Plus' on the left and 'NovoTwist' on the right. The images depict hand placement and attachment method for these injection needles or syringe parts used with insulin administration.*

FDA Label Image

Figure F: Pull Off Inner Needle Cap. (Image 26)

An instructional illustration showing two steps of preparing a NovoLog Mix 70/30 insulin injection using NovoFine or NovoFine Plus and NovoTwist needles. It depicts how to attach or prepare the needle on the syringe prior to administration.*

FDA Label Image

Important (Image 12)

FDA Label Image

Important (Image 13)

FDA Label Image

Important (Image 14)

FDA Label Image

Turn The Dose Selector To 2 Units. (Image 56)

An instructional illustration depicting a hand adjusting an insulin pen dial to select a dose of 2 units. The pen is labeled with dosing indicators, showing the selection of 2 units for injection.*

FDA Label Image

Fig. H (Image 30)

An instructional illustration depicting a finger pressing the top of a syringe or injection device, possibly demonstrating how to operate or prepare the injection for use. The image emphasizes hand placement on the device, relevant to subcutaneous injection techniques.*

FDA Label Image

Press The Push-button. (Image 58)

An instructional illustration showing a hand holding a NovoLog Mix 70/30 injection pen. The image demonstrates pulling off the pen cap by lifting it upwards with an arrow indicating motion, and a small inset shows the proper removal of the cap from the pen.*

FDA Label Image

Select Your Dose. (Image 59)

An instructional illustration showing a hand dialing a dose on an insulin pen. The pen window displays selections of 5 units and 24 units, demonstrating how to select the insulin dose.*

FDA Label Image

Important (Image 15)

FDA Label Image

Press The Push Button To Inject. (Image 60)

Instructional illustration showing how to prepare a NovoLog Mix 70/30 insulin injection. It depicts a hand holding the vial and a syringe, with an arrow indicating to invert or mix the vial before use to ensure proper suspension.*

FDA Label Image

Keep The Needle In The Skin For At Least 6 Seconds. (Image 61)

An instructional illustration showing the injection technique for NovoLog Mix 70/30 (insulin aspart) 100 units/mL suspension. The image depicts a pen injector needle about to be inserted at a shallow angle into the skin, indicating the subcutaneous administration route.*

FDA Label Image

Replace The Pen Cap. (Image 62)

An instructional illustration showing a close-up of a person holding a NovoLog Mix 70/30 injection pen. The image demonstrates how to unlock or prepare the injection pen by rotating or pressing a blue part of the device, indicated by arrows.*

FDA Label Image

Important (Image 16)

FDA Label Image

Important (Image 17)

FDA Label Image

Important (Image 18)

FDA Label Image

Important (Image 19)

FDA Label Image

Important (Image 20)

FDA Label Image

Important (Image 21)

FDA Label Image

Important (Image 22)

FDA Label Image

Important (Image 23)

FDA Label Image

Important (Image 24)

FDA Label Image

Principal Display Panel (VIAL 10ML)

The packaging label for NovoLog Mix 70/30 (insulin aspart protamine and insulin aspart) injectable suspension, 100 units/mL (U-100). It is a 10 mL multiple-dose vial for subcutaneous use, labeled for prescription use only. The label includes storage instructions, manufacturer details (Novo Nordisk Inc.), and a barcode. The product is identified as a human prescription drug by Novo Nordisk Pharmaceutical Industries, LP.*

FDA Label Image

Principal Display Panel – Vial Relion (Image 08)

Packaging label for NovoLog Mix 70/30 injection, suspension containing insulin aspart protamine and insulin aspart at 100 units/mL (U-100) strength. The label indicates a 10 mL multiple-dose vial, intended for subcutaneous use, manufactured by Novo Nordisk. The label includes dosage instructions, storage information, and the ReliOn brand associated with Walmart retail sales.*

FDA Label Image

Principal Display Panel (FLEXPEN 3ML)

Box label for NovoLog Mix 70/30 FlexPen Prefilled Pen injection, suspension containing insulin aspart. The label shows a blue insulin pen with dosage strength 100 units/mL (U-100) and package includes 5 prefilled pens of 3 mL each. The labeler is Novo Nordisk Pharmaceutical Industries, LP. Usage instructions and warnings are present with product images on all sides of the carton.*

FDA Label Image

Principal Display Panel Flexpen Relion (Image 28)

Packaging label for NovoLog Mix 70/30 FlexPen Prefilled Pen containing insulin aspart injectable suspension, 100 units/mL strength. The carton holds five 3 mL prefilled pens for subcutaneous injection. Manufactured by Novo Nordisk Pharmaceutical Industries, LP. The label includes product warnings, storage instructions, barcode, and contact information. It is marked for retail sale by Walmart and affiliates only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.